{"id":14337,"date":"2024-03-14T09:33:00","date_gmt":"2024-03-14T04:03:00","guid":{"rendered":"https:\/\/www.rootsanalysis.com\/blog\/?p=14337"},"modified":"2024-04-05T10:15:57","modified_gmt":"2024-04-05T04:45:57","slug":"antiviral-medications-an-unmet-requirement","status":"publish","type":"post","link":"https:\/\/www.rootsanalysis.com\/blog\/antiviral-medications-an-unmet-requirement\/","title":{"rendered":"Antiviral Medications: An Unmet Requirement in Pharmaceuticals"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Over the past few years, a number of <a href=\"https:\/\/www.rootsanalysis.com\/blog\/antiviral-drugs-development\/\">antiviral drugs<\/a> targeting a myriad of infectious diseases, including human immunodeficiency virus (HIV) infection, hepatitis, herpes simplex virus (HSV) infection, cytomegalovirus (CMV) infection, influenza, coronavirus infection (COVID-19) and others, have received approvals from various regulatory authorities, globally. However, it is important to note that, currently, the approved antiviral medications (around 80) are capable of targeting only 10 of the 220 known viruses that are responsible for causing multiple life threatening infectious diseases in humans. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Further, several of these antiviral medications are being evaluated across multiple clinical trials for the treatment of various infectious diseases. Moreover, post the onset of the COVID-19 pandemic, extensive research is being conducted to evaluate the safety and efficacy of novel antiviral medications. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Presently, more than 375 companies are engaged in the development of over 420 early and late-stage antiviral medications, worldwide. These stakeholders have established multiple partnerships and collaborations in order to advance the development of various pipeline candidates.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"957\" height=\"109\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Antiviral-Drugs-Upcoming-Trends.webp\" alt=\"Antiviral Drugs: Upcoming Trends - Roots Analysis\" class=\"wp-image-18290\" style=\"object-fit:contain;width:840px;height:95px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Antiviral-Drugs-Upcoming-Trends.webp 957w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Antiviral-Drugs-Upcoming-Trends-300x34.webp 300w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Antiviral-Drugs-Upcoming-Trends-768x87.webp 768w\" sizes=\"auto, (max-width: 957px) 100vw, 957px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Most of these drugs are designed to inhibit viral fusion with the host cell, prevent virus replication and protein synthesis, thus inhibiting the reproduction and spread of virus to healthy cells. Some of the mechanism of actions of these drugs are outlined below:<\/p>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"964\" height=\"350\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Mechanism-of-Action-of-Antiviral-Drugs.webp\" alt=\"Mechanism of Action of Antiviral Drugs - Roots Analysis\" class=\"wp-image-18291\" style=\"object-fit:contain;width:840px;height:306px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Mechanism-of-Action-of-Antiviral-Drugs.webp 964w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Mechanism-of-Action-of-Antiviral-Drugs-300x109.webp 300w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Mechanism-of-Action-of-Antiviral-Drugs-768x279.webp 768w\" sizes=\"auto, (max-width: 964px) 100vw, 964px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Approved Antiviral Medications: Current Market Landscape<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Close to 80 antiviral medications have been approved, till date, for the treatment of an array of infectious diseases; nearly 75% of these drugs are administered via oral route. Further, more than 45% of the anti-viral drugs were approved post 2010; majority (~90%) of the approved drugs are small molecules, available in tablet and liquid formulations.<strong> <\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">It is worth highlighting that of the total approved antiivral medications, over 40 drugs have been approved to treat HIV infection, and \u00a0polymerase inhibition is the most common mechanism of action exhibited by majority of the approved antiviral drugs.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"961\" height=\"424\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-List-of-approved-antiviral-drugs.webp\" alt=\"List of approved antiviral drugs 2023 - Roots Analysis\" class=\"wp-image-18292\" style=\"object-fit:contain;width:800px;height:353px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-List-of-approved-antiviral-drugs.webp 961w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-List-of-approved-antiviral-drugs-300x132.webp 300w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-List-of-approved-antiviral-drugs-768x339.webp 768w\" sizes=\"auto, (max-width: 961px) 100vw, 961px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Billions of Dollars are Being Invested in Funding the Initiatives of Various Players Engaged in the Antiviral Drugs Domain<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Maximum number of funding instances (49) were reported in the year 2020, followed by 44 instances, recorded in the year 2021. Further, Most of the funding instances reported by antiviral drug developers were venture capital rounds (30). Given the current trend, it can be inferred that investment from venture funding rounds is a key enabler for the growth in this domain.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"931\" height=\"380\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Funding-and-Investments-Anti-viral-Drugs.webp\" alt=\"Funding and Investments Anti viral drugs - Roots Analysis\" class=\"wp-image-18294\" style=\"object-fit:contain;width:840px;height:343px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Funding-and-Investments-Anti-viral-Drugs.webp 931w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Funding-and-Investments-Anti-viral-Drugs-300x122.webp 300w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/RootsAnalysis-Funding-and-Investments-Anti-viral-Drugs-768x313.webp 768w\" sizes=\"auto, (max-width: 931px) 100vw, 931px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Future Evolution of Antiviral Drugs <\/strong><strong>Market<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">During our research, we estimated the market under conservative, base and optimistic scenarios. As per the base case forecast scenario, the <a href=\"https:\/\/www.rootsanalysis.com\/reports\/antiviral-drugs-market.html\">antiviral drugs market<\/a> is estimated to grow at an annualized rate of 6.3%, in the given time period. The opportunity associated with the antiviral drugs market is likely to be well distributed across various types of drug targets, therapies, and key geographical regions. You can also download the\u00a0<a href=\"https:\/\/www.rootsanalysis.com\/reports\/antiviral-drugs-market\/request-sample.html\">SAMPLE REPORT<\/a>\u00a0on antiviral medications by Roots Analysis.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Key companies engaged in antiviral drugs market\u00a0 AbbVie, AstraZeneca, Bristol-Myers Squibb, Genentech, Gilead Sciences, <a href=\"https:\/\/www.gsk.com\/en-gb\/media\/press-releases\/glaxosmithkline-update-influenza-a-h1n1\/\">GlaxoSmithKline <\/a>(GSK), Johnson &amp; Johnson, Merck, Novartis, Pfizer, Roche and ViiV Healthcare.\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Over the past few years, a number of antiviral drugs targeting a myriad of infectious diseases, including human immunodeficiency virus (HIV) infection, hepatitis, herpes simplex virus (HSV) infection, cytomegalovirus (CMV) infection, influenza, coronavirus infection (COVID-19) and others, have received approvals from various regulatory authorities, globally. However, it is important to note that, currently, the approved [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":16517,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1124],"tags":[1127,1125,1126],"class_list":["post-14337","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-antiviral-drugs","tag-antiviral-drugs-market-article","tag-antiviral-drugs-market-blog","tag-antiviral-drugs-market-updates"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Antiviral Medications: The Unmet Requirements in Pharmaceuticals<\/title>\n<meta name=\"description\" content=\"Antiviral medications are being evaluated across multiple clinical trials for the treatment of various infectious diseases.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rootsanalysis.com\/blog\/antiviral-medications-an-unmet-requirement\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Antiviral Medications: The Unmet Requirements in Pharmaceuticals\" \/>\n<meta property=\"og:description\" content=\"Antiviral medications are being evaluated across multiple clinical trials for the treatment of various infectious diseases.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rootsanalysis.com\/blog\/antiviral-medications-an-unmet-requirement\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RootsAnalysis\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-14T04:03:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-05T04:45:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/04\/RootsAnalysis_FeaturedImage_Virus.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"150\" \/>\n\t<meta property=\"og:image:height\" content=\"150\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Arun Gupta\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:site\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Arun Gupta\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":[\"Article\",\"BlogPosting\"],\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/antiviral-medications-an-unmet-requirement\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/antiviral-medications-an-unmet-requirement\\\/\"},\"author\":{\"name\":\"Arun Gupta\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/af9198bf467c6e126793d9da458a1f62\"},\"headline\":\"Antiviral Medications: An Unmet Requirement in Pharmaceuticals\",\"datePublished\":\"2024-03-14T04:03:00+00:00\",\"dateModified\":\"2024-04-05T04:45:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/antiviral-medications-an-unmet-requirement\\\/\"},\"wordCount\":485,\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/antiviral-medications-an-unmet-requirement\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/RootsAnalysis_FeaturedImage_Virus.webp\",\"keywords\":[\"antiviral drugs market article\",\"antiviral drugs market blog\",\"antiviral drugs market updates\"],\"articleSection\":[\"antiviral drugs\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/antiviral-medications-an-unmet-requirement\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/antiviral-medications-an-unmet-requirement\\\/\",\"name\":\"Antiviral Medications: The Unmet Requirements in Pharmaceuticals\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/antiviral-medications-an-unmet-requirement\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/antiviral-medications-an-unmet-requirement\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/RootsAnalysis_FeaturedImage_Virus.webp\",\"datePublished\":\"2024-03-14T04:03:00+00:00\",\"dateModified\":\"2024-04-05T04:45:57+00:00\",\"description\":\"Antiviral medications are being evaluated across multiple clinical trials for the treatment of various infectious diseases.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/antiviral-medications-an-unmet-requirement\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/antiviral-medications-an-unmet-requirement\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/antiviral-medications-an-unmet-requirement\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/RootsAnalysis_FeaturedImage_Virus.webp\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/RootsAnalysis_FeaturedImage_Virus.webp\",\"width\":150,\"height\":150,\"caption\":\"This is a feature image for blog article Antiviral Medications at Roots Analysis\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/antiviral-medications-an-unmet-requirement\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Antiviral Medications: An Unmet Requirement in Pharmaceuticals\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"name\":\"Blog\",\"description\":\"Roots Analysis\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\",\"name\":\"Roots Analysis\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"width\":205,\"height\":61,\"caption\":\"Roots Analysis\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RootsAnalysis\\\/\",\"https:\\\/\\\/x.com\\\/RootsAnalysis\",\"https:\\\/\\\/www.instagram.com\\\/rootsanalysis\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/roots-analysis\\\/\",\"https:\\\/\\\/www.pinterest.it\\\/analysis1340\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCwZF57vY1lnU0bNLej2zukg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/af9198bf467c6e126793d9da458a1f62\",\"name\":\"Arun Gupta\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g\",\"caption\":\"Arun Gupta\"},\"description\":\"Arun is an enthusiastic professional and has been associated with Roots Analysis since the very early years. He has led multifaceted roles over the years be it business research, consulting, competitive intelligence, IT &amp; technology, sales and marketing. He currently drives strategic thinking and execution within the sales and marketing domain. With educational background in life sciences from Thapar University and digital marketing credentials from Indian School of Business, he has led a lot of critical initiatives at the organization. His background in life sciences has been one of the key reasons for quick understanding and implementation of customized marketing strategies. During his early years, he has led multiple consulting assignments for global clients ranging from competitive landscaping, deal structuring and preparing go-to-market strategy for his clients.\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Antiviral Medications: The Unmet Requirements in Pharmaceuticals","description":"Antiviral medications are being evaluated across multiple clinical trials for the treatment of various infectious diseases.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rootsanalysis.com\/blog\/antiviral-medications-an-unmet-requirement\/","og_locale":"en_US","og_type":"article","og_title":"Antiviral Medications: The Unmet Requirements in Pharmaceuticals","og_description":"Antiviral medications are being evaluated across multiple clinical trials for the treatment of various infectious diseases.","og_url":"https:\/\/www.rootsanalysis.com\/blog\/antiviral-medications-an-unmet-requirement\/","og_site_name":"Blog","article_publisher":"https:\/\/www.facebook.com\/RootsAnalysis\/","article_published_time":"2024-03-14T04:03:00+00:00","article_modified_time":"2024-04-05T04:45:57+00:00","og_image":[{"width":150,"height":150,"url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/04\/RootsAnalysis_FeaturedImage_Virus.webp","type":"image\/webp"}],"author":"Arun Gupta","twitter_card":"summary_large_image","twitter_creator":"@RootsAnalysis","twitter_site":"@RootsAnalysis","twitter_misc":{"Written by":"Arun Gupta","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["Article","BlogPosting"],"@id":"https:\/\/www.rootsanalysis.com\/blog\/antiviral-medications-an-unmet-requirement\/#article","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/antiviral-medications-an-unmet-requirement\/"},"author":{"name":"Arun Gupta","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/af9198bf467c6e126793d9da458a1f62"},"headline":"Antiviral Medications: An Unmet Requirement in Pharmaceuticals","datePublished":"2024-03-14T04:03:00+00:00","dateModified":"2024-04-05T04:45:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/antiviral-medications-an-unmet-requirement\/"},"wordCount":485,"publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/antiviral-medications-an-unmet-requirement\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/04\/RootsAnalysis_FeaturedImage_Virus.webp","keywords":["antiviral drugs market article","antiviral drugs market blog","antiviral drugs market updates"],"articleSection":["antiviral drugs"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.rootsanalysis.com\/blog\/antiviral-medications-an-unmet-requirement\/","url":"https:\/\/www.rootsanalysis.com\/blog\/antiviral-medications-an-unmet-requirement\/","name":"Antiviral Medications: The Unmet Requirements in Pharmaceuticals","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/antiviral-medications-an-unmet-requirement\/#primaryimage"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/antiviral-medications-an-unmet-requirement\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/04\/RootsAnalysis_FeaturedImage_Virus.webp","datePublished":"2024-03-14T04:03:00+00:00","dateModified":"2024-04-05T04:45:57+00:00","description":"Antiviral medications are being evaluated across multiple clinical trials for the treatment of various infectious diseases.","breadcrumb":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/antiviral-medications-an-unmet-requirement\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rootsanalysis.com\/blog\/antiviral-medications-an-unmet-requirement\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/antiviral-medications-an-unmet-requirement\/#primaryimage","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/04\/RootsAnalysis_FeaturedImage_Virus.webp","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/04\/RootsAnalysis_FeaturedImage_Virus.webp","width":150,"height":150,"caption":"This is a feature image for blog article Antiviral Medications at Roots Analysis"},{"@type":"BreadcrumbList","@id":"https:\/\/www.rootsanalysis.com\/blog\/antiviral-medications-an-unmet-requirement\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rootsanalysis.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Antiviral Medications: An Unmet Requirement in Pharmaceuticals"}]},{"@type":"WebSite","@id":"https:\/\/www.rootsanalysis.com\/blog\/#website","url":"https:\/\/www.rootsanalysis.com\/blog\/","name":"Blog","description":"Roots Analysis","publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rootsanalysis.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization","name":"Roots Analysis","url":"https:\/\/www.rootsanalysis.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","width":205,"height":61,"caption":"Roots Analysis"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RootsAnalysis\/","https:\/\/x.com\/RootsAnalysis","https:\/\/www.instagram.com\/rootsanalysis\/","https:\/\/www.linkedin.com\/company\/roots-analysis\/","https:\/\/www.pinterest.it\/analysis1340\/","https:\/\/www.youtube.com\/channel\/UCwZF57vY1lnU0bNLej2zukg"]},{"@type":"Person","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/af9198bf467c6e126793d9da458a1f62","name":"Arun Gupta","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g","caption":"Arun Gupta"},"description":"Arun is an enthusiastic professional and has been associated with Roots Analysis since the very early years. He has led multifaceted roles over the years be it business research, consulting, competitive intelligence, IT &amp; technology, sales and marketing. He currently drives strategic thinking and execution within the sales and marketing domain. With educational background in life sciences from Thapar University and digital marketing credentials from Indian School of Business, he has led a lot of critical initiatives at the organization. His background in life sciences has been one of the key reasons for quick understanding and implementation of customized marketing strategies. During his early years, he has led multiple consulting assignments for global clients ranging from competitive landscaping, deal structuring and preparing go-to-market strategy for his clients."}]}},"_links":{"self":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/14337","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/comments?post=14337"}],"version-history":[{"count":11,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/14337\/revisions"}],"predecessor-version":[{"id":21548,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/14337\/revisions\/21548"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media\/16517"}],"wp:attachment":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media?parent=14337"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/categories?post=14337"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/tags?post=14337"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}